Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with portal hypertension

Yaru TONG; Xiaochun YIN; Wei ZHANG; Chang SUN; Ming ZHANG; Yuzheng ZHUGE

doi:10.3969/j.issn.1001-5256.2023.02.012

Volume 39 Issue 2

Feb. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(2): 333-338

PDF( 2133 KB)

Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with portal hypertension

DOI: 10.3969/j.issn.1001-5256.2023.02.012

Department of Gastroenterology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China

Research funding:

National Natural Science Found (82100652)

More Information

Corresponding author: ZHUGE Yuzheng, yuzheng911963@aliyun.com (ORCID: 0000-0002-3829-5831)
Received Date: 2022-07-15
Accepted Date: 2022-08-22
Published Date: 2023-02-20

Abstract

Abstract

Objective To investigate the long-term efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of primary biliary cholangitis (PBC) with portal hypertension. Methods A retrospective analysis was performed for 102 patients who received TIPS in Affiliated Drum Tower Hospital of Nanjing University Medical School from January 2015 to August 2021, and these patients were divided into PBC group with 41 patients and viral hepatitis cirrhosis group with 81 patients. Related indicators were collected, including routine blood test results, liver and renal function, coagulation function, portal vein thrombosis, hepatic encephalopathy, and etiology of TIPS treatment shortly after admission, preoperative portal venous pressure, and stents used in surgery, and Child-Pugh score was calculated. Follow-up data were collected and analyzed, including postoperative upper gastrointestinal rebleeding, stent dysfunction, hepatic encephalopathy, and the data on survival and prognosis. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of continuous data with skewed distribution between two groups; the chi-square test was used for comparison of categorical data between two groups. The Kaplan-Meier method was used for survival analysis, and the log-rank test was used for survival difference analysis. Results In the PBC group and the viral hepatitis cirrhosis group, the median percentage of reduction in portal venous pressure after surgery was 33.00% and 35.00%, respectively, and there was no significant difference between the two groups (P > 0.05). At the end of follow-up, there were no significant differences between the PBC group and the viral hepatitis cirrhosis group in stent dysfunction rate (14.63% vs 24.69%, χ²=1.642, P > 0.05), upper gastrointestinal rebleeding rate (17.07% vs 24.69%, χ²=0.917, P > 0.05), the incidence rate of overt hepatic encephalopathy (12.20% vs 7.41%, χ²=0.289, P > 0.05), and disease-specific death rate (14.63% vs 9.88%, χ²=0.229, P > 0.05). Conclusion For PBC patients with portal hypertension, TIPS can achieve the same efficacy as the treatment of portal hypertension caused by viral hepatitis cirrhosis and can also effectively reduce portal hypertension without increasing the incidence rate of complications and disease-specific death rate. Therefore, it is a safe and effective treatment method.
- Liver Cirrhosis, Biliary,
- Hepatitis, Viral, Human,
- Liver Cirrhosis,
- Portasystemic Shunt, Transjugular Intrahepatic,
- Hypertension, Portal

FullText(HTML)

References(18)

References

[1]	CAREY EJ, ALI AH, LINDOR KD. Primary biliary cirrhosis[J]. Lancet, 2015, 386(10003): 1565-1575. DOI: 10.1016/S0140-6736(15)00154-3.
[2]	RESHETNYAK Ⅵ. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis[J]. World J Gastroenterol, 2015, 21(25): 7683-7708. DOI: 10.3748/wjg.v21.i25.7683.
[3]	SIMONETTO DA, LIU M, KAMATH PS. Portal hypertension and related complications: diagnosis and management[J]. Mayo Clin Proc, 2019, 94(4): 714-726. DOI: 10.1016/j.mayocp.2018.12.020.
[4]	WARNES TW, ROBERTS SA, SMITH A, et al. Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates[J]. Eur J Gastroenterol Hepatol, 2021, 33(12): 1595-1602. DOI: 10.1097/MEG.0000000000002033.
[5]	PARÉS A. Primary biliary cholangitis[J]. Med Clin (Barc), 2018, 151(6): 242-249. DOI: 10.1016/j.medcli.2017.12.021.
[6]	RAJESH S, GEORGE T, PHILIPS CA, et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update[J]. World J Gastroenterol, 2020, 26(37): 5561-5596. DOI: 10.3748/wjg.v26.i37.5561.
[7]	YIN X, ZHANG F, XIAO J, et al. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients[J]. Eur J Gastroenterol Hepatol, 2019, 31(10): 1264-1269. DOI: 10.1097/MEG.0000000000001452.
[8]	HUNG ML, LEE EW. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature[J]. Clin Liver Dis, 2019, 23(4): 737-754. DOI: 10.1016/j.cld.2019.07.004.
[9]	WANG X, ZHANG W, ZHANG M, et al. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome[J]. Hepatol Int, 2022, 16(3): 669-679. DOI: 10.1007/s12072-021-10293-5.
[10]	YIN XC, ZHANG F, XIAO JQ, et al. Efficacy analysis of transjugular intrahepatic portosystemic shunt in the treatment of esophago-gastric variceal bleeding complicated with cavernous transformation of the portal vein[J]. Chin J Dig, 2021, 41(10): 685-691. DOI: 10.3760/cma.j.cn311367-20210103-00004. 尹晓春, 张峰, 肖江强, 等. 经颈静脉肝内门体分流术治疗食管-胃底静脉曲张破裂出血伴门静脉海绵样变的疗效分析[J]. 中华消化杂志, 2021, 41(10): 685-691. DOI: 10.3760/cma.j.cn311367-20210103-00004.
[11]	VILELA EG, THABUT D, RUDLER M, et al. Management of Complications of Portal Hypertension[J]. Can J Gastroenterol Hepatol, 2019, 2019: 6919284. DOI: 10.1155/2019/6919284
[12]	VILSTRUP H, AMODIO P, BAJAJ J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J]. Hepatology, 2014, 60(2): 715-735. DOI: 10.1002/hep.27210.
[13]	WEISSENBORN K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles[J]. Drugs, 2019, 79(Suppl 1): 5-9. DOI: 10.1007/s40265-018-1018-z.
[14]	PERARNAU JM, LE GOUGE A, NICOLAS C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial[J]. J Hepatol, 2014, 60(5): 962-968. DOI: 10.1016/j.jhep.2014.01.015.
[15]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary biliary cholangitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794. 中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794.
[16]	TANAKA A. Current understanding of primary biliary cholangitis[J]. Clin Mol Hepatol, 2021, 27(1): 1-21. DOI: 10.3350/cmh.2020.0028.
[17]	GULAMHUSEIN AF, HIRSCHFIELD GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(2): 93-110. DOI: 10.1038/s41575-019-0226-7.
[18]	European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1): 145-172. DOI: 10.1016/j.jhep.2017.03.022.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (614) PDF downloads(75)

Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with portal hypertension

DOI: 10.3969/j.issn.1001-5256.2023.02.012

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content